Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiska Weisblum

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Virology|December 16, 2016
Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal InterfaceYiska Weisblum, Esther Oiknine-Djian, Olesya M Vorontsov, et al.
Cell Reports|June 7, 2016
CEACAM1-Mediated Inhibition of Virus ProductionAlon Vitenshtein, Yiska Weisblum, Sebastian Hauka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
The Journal of Experimental Medicine|July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Elife|October 28, 2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsYiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsYiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Virology|December 16, 2016
Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal InterfaceYiska Weisblum, Esther Oiknine-Djian, Olesya M Vorontsov, et al.
Cell Reports|June 7, 2016
CEACAM1-Mediated Inhibition of Virus ProductionAlon Vitenshtein, Yiska Weisblum, Sebastian Hauka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
The Journal of Experimental Medicine|July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Elife|October 28, 2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsYiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsYiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
Pageof 5